Russia's 36.6 makes appointments
This article was originally published in Scrip
One of Russia's largest pharmacy chains, The Pharmacy Chain 36.6, has made several appointments. Ruslan Vorobel has joined from the Metro group to become the company's commercial director. Andrey Atemasov has been appointed head of its marketing department; he previously worked for various firms including Williams-Sonoma and Redenvelope. Marina Ivanova has moved from the Russian supermarket chain Perekrestok to become The Pharmacy Chain 36.6's director of human resources. Alexey Skrypnikov, who was previously executive director of another local pharmacy chain, Stariy Lekar, has been appointed head of The Pharmacy Chain 36.6's business unit for Moscow and central Russia. Cyril Ivanov has become director of operations in the regions, Alexandra Kozhaeva director of procurement, and the responsibilities of Dmitriy Godunov, The Pharmacy Chain 36.6's first deputy director general, have been expanded to cover logistics control across Russia.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.